The Smoking Cessation Efficacy of Varying Doses of Nicotine Patch Delivery Systems 4 to 5 Years Post-Quit Day
Authors:
- Stephen P. FortmannSFStephen P. Fortmann
- Elbert D. GloverEGElbert D. Glover
- Dorothy K. HatsukamiDHDorothy K. Hatsukami
- Scott A. HeatleySHScott A. Heatley
- Edward LichtensteinELEdward Lichtenstein
- Lawrence RepsherLRLawrence Repsher
- Tajuddin MillatmalTMTajuddin Millatmal
- Joel D. KillenJKJoel D. Killen
- Robert T. NowakRNRobert T. Nowak
- Fred UllrichFUFred Ullrich
- Kashinath D. PatilKPKashinath D. Patil
- 1 February 1999
- journal article
- clinical trial
- Published by Elsevier in Preventive Medicine
- Vol. 28 (2) , 113-118
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Three year continuous abstinence in a smoking cessation study using the nicotine transdermal patchHeart, 1997
- The Influence of Smoking Cessation on the Prevalence of Overweight in the United StatesNew England Journal of Medicine, 1995
- Dose effects and predictors of outcome in a randomized trial of transdermal nicotine patches in general practiceAddiction, 1995
- Randomised trial of nicotine patches in general practice: results at one yearBMJ, 1994
- Nicotine Patch Therapy for Smoking Cessation Combined With Physician Advice and Nurse Follow-upJAMA, 1994
- Transdermal Nicotine for Smoking CessationJAMA, 1991
- A Double-Blind Trial of a 16-Hour Transdermal Nicotine Patch in Smoking CessationNew England Journal of Medicine, 1991
- Effect of Transdermal Nicotine Delivery as an Adjunct to Low-Intervention Smoking Cessation TherapyArchives of internal medicine (1960), 1991
- Smoking Cessation and Severity of Weight Gain in a National CohortNew England Journal of Medicine, 1991
- Measuring nicotine dependence: A review of the Fagerstrom Tolerance QuestionnaireJournal of Behavioral Medicine, 1989